Loading data
HLSQNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 21.29 m USD | 24.66 m USD | 16.7 m USD | 16.24 m USD | 22.68 m USD |
| Operating profit | -41.47 m USD | -44.52 m USD | -25.35 m USD | -27.22 m USD | -35.46 m USD |
| Interest expense | — | — | 2.4 m USD | 2.07 m USD | 699 k USD |
| Profit before tax | -36.19 m USD | -17.71 m USD | -26.15 m USD | -28.25 m USD | -36.16 m USD |
| Income tax expense | 7 k USD | 13 k USD | 23 k USD | 65 k USD | 67 k USD |
| Net income (reported basis) | -36.2 m USD | -17.73 m USD | 26.17 m USD | 28.32 m USD | -36.23 m USD |
| Net income attributable to common shareholders | — | -17.73 m USD | -26.17 m USD | — | — |
| Basic earnings per share | 22.19 USD/share | 25.37 USD/share | 5.1 USD/share | 0.95 USD/share | 1.39 USD/share |
| Diluted earnings per share | 22.19 USD/share | 58.31 USD/share | 5.1 USD/share | 0.95 USD/share | 1.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.